![Jan-Uwe Claas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan-Uwe Claas
Directeur Général chez
Grünenthal NV
Health Technology
Profil
Jan-Uwe Claas currently works at Grünenthal NV, as Co-Managing Director & Director from 2018 and PROVIREX Genome Editing Therapies GmbH, as Co-Managing Director.
Postes actifs de Jan-Uwe Claas
| Sociétés | Poste | Début |
|---|---|---|
Grünenthal NV
 Grünenthal NV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drugs | Directeur Général | 01/02/2018 |
PROVIREX Genome Editing Therapies GmbH
 PROVIREX Genome Editing Therapies GmbH Pharmaceuticals: MajorHealth Technology Manufactures advanced therapy medicinal products | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Grünenthal NV
Grünenthal NV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drugs | Health Technology |
PROVIREX Genome Editing Therapies GmbH
PROVIREX Genome Editing Therapies GmbH Pharmaceuticals: MajorHealth Technology Manufactures advanced therapy medicinal products | Health Technology |
Choisissez Zonebourse 
